跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
洪 晧彰
Doctor
內科部
電子郵件
haochang.hung
gmail
com
h-index
739
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2006
2024
每年研究成果
概覽
指紋
網路
研究成果
(39)
類似的個人檔案
(6)
指紋
查看啟用 Hao-Chang Hung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Self-reported Sleep Quality
90%
Pre-diabetes (pre-DM)
74%
Impaired Fasting Glucose
72%
Hedgehog Proteins
66%
Hepassocin
66%
Impaired Glucose Tolerance
61%
Non-alcoholic Fatty Liver Disease (NAFLD)
57%
New-onset Diabetes
53%
Pittsburgh Sleep Quality Index
44%
Diet-induced
42%
High Glucose
38%
Hepatic Steatosis
38%
Index Score
36%
Type 2 Diabetes Mellitus (T2DM)
35%
HepG2 Cells
35%
Poor Sleep
35%
High-fat Diet
35%
Hepatokine
35%
Normal Glucose Tolerance
34%
Growth Differentiation factor-15 (GDF-15)
33%
Secretogranin III
33%
Lipopolysaccharide-induced Inflammation
33%
Menopause
33%
CT-1
33%
GPR40
33%
Fomitopsis pinicola
33%
Multiple Mechanisms
33%
Glucose-insulin System
33%
Fungal Extracts
33%
Vasomotor Symptoms
33%
Fetuin-A
33%
Corticosterone
33%
F-18 Fluorodeoxyglucose
33%
Autoimmune Thyroiditis
33%
Dietary Fatty Acids
33%
Protein Level
33%
Signal Transducer and Activator of Transcription 3
33%
Obese Subjects
33%
Endoplasmic Reticulum Stress (ER stress)
33%
Anti-obesity
33%
Unsaturated Fatty Acids
33%
Insulin Resistance
33%
Non-obese
33%
Nodular Goiter
33%
Graves' Ophthalmopathy
33%
Amiodarone-induced Thyrotoxicosis
33%
Subclinical Hypothyroidism
33%
Fibrinogen-related Protein
33%
Anti-osteoporosis
33%
Free Fatty Acid Receptors
33%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide
94%
Non Insulin Dependent Diabetes Mellitus
66%
Cardiotrophin 1
66%
G Protein Coupled Receptor 40
66%
Metabolic Syndrome X
66%
Inflammation
62%
High Density Lipoprotein Cholesterol
47%
Impaired Glucose Tolerance
47%
Fatty Liver
46%
Cytokine
45%
Triacylglycerol
41%
Nonalcoholic Fatty Liver
41%
Diabetes Mellitus
41%
Fetuin A
39%
Biological Marker
33%
Sleep Disorder
33%
Helicobacter pylori
33%
STAT3 Protein
33%
Fungal Extract
33%
Fomitopsis
33%
Infection
33%
Helicobacter Infection
33%
Fenretinide
33%
Corticosterone
33%
Peroxisome Proliferator Activated Receptor Gamma
33%
Alanine Aminotransferase
33%
Lipopolysaccharide-Induced Inflammation
33%
Dietary Fat
33%
Antiobesity Drugs
33%
Unsaturated Fatty Acid
33%
Subclinical Hypothyroidism
33%
Nodular Goiter
33%
Hedgehog
33%
Spontaneously Hypertensive Rat
33%
Strontium Ranelate
33%
Selective Estrogen Receptor Modulator
33%
Bisphosphonic Acid Derivative
33%
Endocrine Ophthalmopathy
33%
Lead Fracture
33%
Calcitonin
33%
Glucocorticoid
33%
Glucagon Like Peptide 1 Receptor Agonist
33%
Degenerative Disease
31%
Oleic Acid
30%
Hemoglobin A1c
30%
Interleukin 6
27%
Fatty Acid
25%
Tumor Necrosis Factor
22%
Nervous System Inflammation
21%
Glucagon-Like Peptide-1
19%
Medicine and Dentistry
Diabetes
100%
Impaired Glucose Tolerance
73%
Glycemic Control
66%
Impaired Fasting Glucose
54%
Hemoglobin A1c
41%
Glycemic
40%
Maturity Onset Diabetes of the Young
37%
Patient with Type 2 Diabetes
33%
Arterial Stiffness
33%
Growth Differentiation Factor 15
33%
Microglia
33%
Cardiotrophin 1
33%
Hyperglycemia
33%
Placebo
33%
Oxidative Stress
33%
Sleep Quality
33%
Metabolic Syndrome
33%
Helicobacter Infection
33%
Serositis
33%
Infection
33%
Antiobesity Drugs
33%
Subclinical Hypothyroidism
33%
Fetuin A
33%
Helicobacter pylori
33%
Endocrine Ophthalmopathy
33%
Nodular Goiter
33%
Patient with Diabetes
33%
Lipopolysaccharide
33%
Non-Alcoholic Fatty Liver Disease
33%
Glucose Tolerance
32%
Pittsburgh Sleep Quality Index
31%
Oral Antidiabetic Agent
18%
Pulse Wave Velocity
14%
Urea Breath Test
14%
Neuroinflammation
13%
Biological Marker
12%
Thyroid Incidentaloma
11%
Autoimmune Thyroiditis
11%
Complementary Therapy
11%
Orlistat
11%
Rimonabant
11%
Sibutramine
11%
Thyroxine
11%
Cardiometabolic Risk
10%
Cardiovascular Disease
9%
Cancer
9%
Graves' Disease
9%
Macrophage
9%
Multiple Linear Regression Analysis
8%
Enzyme Linked Immunosorbent Assay
7%
